722 related articles for article (PubMed ID: 20077416)
21. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
Liao PC; Ng LT; Lin LT; Richardson CD; Wang GH; Lin CC
J Med Food; 2010 Dec; 13(6):1415-23. PubMed ID: 20946021
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line.
Lin HY; Shih A; Davis FB; Tang HY; Martino LJ; Bennett JA; Davis PJ
J Urol; 2002 Aug; 168(2):748-55. PubMed ID: 12131363
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
Wolter F; Akoglu B; Clausnitzer A; Stein J
J Nutr; 2001 Aug; 131(8):2197-203. PubMed ID: 11481417
[TBL] [Abstract][Full Text] [Related]
24. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
25. Effects of resveratrol and other wine polyphenols on the proliferation, apoptosis and androgen receptor expression in LNCaP cells.
Ferruelo A; Romero I; Cabrera PM; Arance I; Andrés G; Angulo JC
Actas Urol Esp; 2014; 38(6):397-404. PubMed ID: 24726691
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo.
Wang TT; Hudson TS; Wang TC; Remsberg CM; Davies NM; Takahashi Y; Kim YS; Seifried H; Vinyard BT; Perkins SN; Hursting SD
Carcinogenesis; 2008 Oct; 29(10):2001-10. PubMed ID: 18586690
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effect of resveratrol in human prostate carcinoma cells.
Kim YA; Rhee SH; Park KY; Choi YH
J Med Food; 2003; 6(4):273-80. PubMed ID: 14977434
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptors.
Wang C; Hu ZQ; Chu M; Wang Z; Zhang WG; Wang LZ; Li CG; Wang JS
Clin Neurol Neurosurg; 2012 Apr; 114(3):241-8. PubMed ID: 22104698
[TBL] [Abstract][Full Text] [Related]
29. Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.
Horvath Z; Marihart-Fazekas S; Saiko P; Grusch M; Ozsüy M; Harik M; Handler N; Erker T; Jaeger W; Fritzer-Szekeres M; Djavan B; Szekeres T
Anticancer Res; 2007; 27(5A):3459-64. PubMed ID: 17970095
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells.
Yoo KM; Kim S; Moon BK; Kim SS; Kim KT; Kim SY; Choi SY
Arch Pharm (Weinheim); 2006 May; 339(5):238-41. PubMed ID: 16619281
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
Joe AK; Liu H; Suzui M; Vural ME; Xiao D; Weinstein IB
Clin Cancer Res; 2002 Mar; 8(3):893-903. PubMed ID: 11895924
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol-induced gene expression profiles in human prostate cancer cells.
Jones SB; DePrimo SE; Whitfield ML; Brooks JD
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):596-604. PubMed ID: 15767336
[TBL] [Abstract][Full Text] [Related]
34. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of antitumor effects of two vine stalk oligomers of resveratrol on a panel of lymphoid and myeloid cell lines: comparison with resveratrol.
Barjot C; Tournaire M; Castagnino C; Vigor C; Vercauteren J; Rossi JF
Life Sci; 2007 Nov; 81(23-24):1565-74. PubMed ID: 18001803
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol enhances mitomycin C-mediated suppression of human colorectal cancer cell proliferation by up-regulation of p21WAF1/CIP1.
Ali I; Braun DP
Anticancer Res; 2014 Oct; 34(10):5439-46. PubMed ID: 25275039
[TBL] [Abstract][Full Text] [Related]
37. Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism.
Hsieh TC; Wu JM
Anticancer Res; 2000; 20(1A):225-8. PubMed ID: 10769659
[TBL] [Abstract][Full Text] [Related]
38. Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells.
Larrosa M; Tomás-Barberán FA; Espín JC
J Agric Food Chem; 2003 Jul; 51(16):4576-84. PubMed ID: 14705880
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol analog, 3,5,2',4'-tetramethoxy-trans-stilbene, potentiates the inhibition of cell growth and induces apoptosis in human cancer cells.
Nam KA; Kim S; Heo YH; Lee SK
Arch Pharm Res; 2001 Oct; 24(5):441-5. PubMed ID: 11693548
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells.
Sala G; Minutolo F; Macchia M; Sacchi N; Ghidoni R
Drugs Exp Clin Res; 2003; 29(5-6):263-9. PubMed ID: 15134383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
